Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
80%(4 trials)

Phase Distribution

Ph phase_1
1
14%
Ph phase_2
3
43%
Ph not_applicable
3
43%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
3(42.9%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (14.3%)
Phase 23 (42.9%)
N/A3 (42.9%)

Trials by Status

completed571%
not_yet_recruiting114%
withdrawn114%

Recent Activity

0 active trials
Showing 5 of 7
not_yet_recruitingnot_applicable

Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study

NCT05400408
completednot_applicable

Detection of COVID-19 Using Breath Analysis - Validation Study.

NCT05224622
withdrawnnot_applicable

Detection of Bacterial and Viral Pathogens Infection Among Hospitalized Patients Feasibility Study

NCT05399615
completedphase_1

Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

NCT02533427
completedphase_2

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection

NCT02378935
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05400408Not Applicable

Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study

Not Yet Recruiting
NCT05224622Not Applicable

Detection of COVID-19 Using Breath Analysis - Validation Study.

Completed
NCT05399615Not Applicable

Detection of Bacterial and Viral Pathogens Infection Among Hospitalized Patients Feasibility Study

Withdrawn
NCT02533427Phase 1

Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

Completed
NCT02378935Phase 2

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection

Completed
NCT02378961Phase 2

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection

Completed
NCT02202980Phase 2

Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection

Completed

All 7 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
7